Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Gw Pharma ADR (GWPH)

Gw Pharma ADR (GWPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,027,107
  • Shares Outstanding, K 31,047
  • Annual Sales, $ 311,330 K
  • Annual Income, $ -9,020 K
  • 60-Month Beta 1.94
  • Price/Sales 12.73
  • Price/Cash Flow N/A
  • Price/Book 5.39
Trade GWPH with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.77
  • Number of Estimates 10
  • High Estimate -0.36
  • Low Estimate -1.20
  • Prior Year -0.84
  • Growth Rate Est. (year over year) +8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.07 +48.98%
on 10/29/20
130.31 -0.46%
on 11/27/20
+38.96 (+42.93%)
since 10/27/20
3-Month
87.07 +48.98%
on 10/29/20
130.31 -0.46%
on 11/27/20
+26.48 (+25.65%)
since 08/27/20
52-Week
67.98 +90.81%
on 03/17/20
141.98 -8.64%
on 07/15/20
+29.28 (+29.15%)
since 11/27/19

Most Recent Stories

More News
Cannabis Beverage Market Size 2020 with Covid 19 Impact Analysis includes Top Countries Data, Applications, Trends and Forecast to 2028

New York, United States, Fri, 20 Nov 2020 05:43:34 / Comserve Inc. / -- The cannabis beverage market is projected to witness a CAGR of more than 15% over the period 2020-2028.

ACB.TO : 13.74 (+17.94%)
MEDFF : 18.8100 (-0.37%)
WEED.TO : 37.50 (+7.36%)
APHA : 7.73 (+10.27%)
CRON : 8.47 (+6.27%)
GWPH : 129.71 (+1.65%)
CNTTQ : 0.1620 (-4.71%)
VIVO : 18.74 (+5.52%)
TLRY : 8.50 (+13.79%)
OGI : 1.3300 (+9.02%)
ACB : 10.47 (+20.21%)
Findit Features Members Global WholeHealth Partners, WynCore and OTC Tip Reporter

ATLANTA, GA / ACCESSWIRE / November 17, 2020 / Findit, Inc. (OTC PINK:) owner of , a full-service social networking platform which provides online marketing campaigns and tools for members to increase...

FDIT : 0.1380 (-4.17%)
GWPH : 129.71 (+1.65%)
Should You Buy Cannabis Stocks & ETFs Now?

CNBC's cannabis expert Tim Seymour discusses the recent developments in the space.

GWPH : 129.71 (+1.65%)
IIPR : 156.79 (+0.33%)
CGC : 29.00 (+7.93%)
CRON : 8.47 (+6.27%)
APHA : 7.73 (+10.27%)
GRWG : 35.59 (+6.14%)
CNBS : 17.90 (+5.40%)
Greenwich Biosciences to Present Analysis of Three Clinical Studies of Nabiximols for People with Multiple Sclerosis Related Spasticity at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly

- Results from analysis of three Phase 3 clinical studies showed statistically significant improvement in spasticity in people with multiple sclerosis

GWPH : 129.71 (+1.65%)
GW Pharmaceuticals to Present at the Stifel 2020 Virtual Healthcare Conference

GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company...

GWPH : 129.71 (+1.65%)
Is Innovative Industrial Properties a Buy After Earnings?

Innovative Industrial Properties (IIPR) reported its latest financial results this week and they were spectacular. Learn what this means for the company and if you should consider buying the stock. ...

IIPR : 156.79 (+0.33%)
GWPH : 129.71 (+1.65%)
Why Shares of GW Pharmaceuticals are a Buy for 2021

Cannabis investors got come good news this week as GW Pharmaceuticals (GWPH) reported better than expected results. Learn what drove these results and what they mean for the company going forward. ...

GWPH : 129.71 (+1.65%)
MJ : 15.21 (+5.99%)
Medical Cannabis Market Report 2020: Industry Trends, Share, Size, Demand, COVID-19 Impact Analysis, And Future Scope

Global Medical Cannabis Market Report by Derivative (Cannabidiol (CBD), Tetrahydrocannabinol (THC), Others), Species (Indica, Sativa, Hybrid), Application (Cancer, Arthritis, Migraine, Epilepsy, Others),...

APHA : 7.73 (+10.27%)
ACB.TO : 13.74 (+17.94%)
CBDS : 0.5800 (+16.58%)
INSY : 0.29 (unch)
MEDFF : 18.8100 (-0.37%)
CNAB : 0.0165 (-65.63%)
GWPH : 129.71 (+1.65%)
ACB : 10.47 (+20.21%)
Back-to-Back Rallies Heading into the Election

Back-to-Back Rallies Heading into the Election

CDMO : 8.94 (+1.82%)
DBD : 10.02 (+1.21%)
WWW : 30.14 (-1.18%)
COP : 42.78 (-1.95%)
TTD : 873.10 (+1.26%)
GOOS : 34.05 (-4.35%)
AMT : 234.09 (+0.47%)
MRNA : 127.03 (+16.35%)
SQM : 48.15 (-0.39%)
EDIT : 31.34 (+6.42%)
ACB : 10.47 (+20.21%)
GWPH : 129.71 (+1.65%)
PINS : 69.72 (+3.41%)
Why Cannabis Stocks & ETFs Are Soaring

Marijuana stocks are rising on hopes of favorable regulatory environment

GWPH : 129.71 (+1.65%)
CGC : 29.00 (+7.93%)
CRON : 8.47 (+6.27%)
ACB : 10.47 (+20.21%)
MJ : 15.21 (+5.99%)
YOLO : 16.59 (+5.40%)
TOKE : 14.95 (+4.40%)
CNBS : 17.90 (+5.40%)
MSOS : 32.68 (+3.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and...

See More

Key Turning Points

2nd Resistance Point 131.98
1st Resistance Point 130.85
Last Price 129.71
1st Support Level 128.04
2nd Support Level 126.36

See More

52-Week High 141.98
Last Price 129.71
Fibonacci 61.8% 113.71
Fibonacci 50% 104.98
Fibonacci 38.2% 96.25
52-Week Low 67.98

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar